Summary
- Introduction: The study focused on the development and characteristics of LNCaP spheroids in an in-vivo model to better understand prostate cancer progression.
- Objectives: The study aimed to assess spheroid morphology, doubling time, cell count, viability, tumor engraftment, metastasis, tumor volume, and PSA levels in an orthotopic model.
- Methods: LNCaP spheroids were generated using ultra-low attachment plates and implanted in mice for tumor growth evaluation without specifying statistical software.
- Findings: Spheroids showed slower growth and longer doubling times compared to monolayer cultures, with spheroid tumors reaching larger volumes and higher PSA levels in a 20-week follow-up period.
- Conclusion and Recommendations: The study validated serum PSA as a non-invasive measure of tumor burden and highlighted the significance of spheroids in modeling prostate cancer progression for future research and treatment strategies.
In a recent study, researchers investigated the morphology and growth patterns of LNCaP spheroids in a 96-well plate system. Small cell clusters formed spheroids within ten days, with larger spheroids having longer doubling times. Cell count and viability increased over a ten-day period, with spheroids initiated with more cells showing higher cell counts. However, viability remained steady at 50-85% across all spheroid groups.
The study also examined the engraftment and metastatic potential of LNCaP spheroids in mice. Successful intraprostatic implantation of spheroids led to tumor growth and metastases, with spheroid tumors showing faster growth rates than monolayer tumors. PSA levels correlated with tumor burden, providing a non-invasive measure of tumor progression.
Histological evaluation of primary tumors and metastases revealed solid tumor masses with prominent nucleoli and infiltrative growth patterns. Immunohistochemical analysis showed expression of Ki-67, AR, E-Cadherin, CK8, AMACR, and Vimentin in both primary tumors and metastases, indicating the characteristics of prostate cancer cells.
Overall, the study findings demonstrate the potential of LNCaP spheroids as a model for studying prostate cancer growth and metastasis. The correlation between sonographic tumor volume and PSA levels validates the use of PSA as a biomarker for disease progression. Understanding the behavior of spheroids in an orthotopic model can provide valuable insights into prostate cancer biology and potential therapeutic strategies. Further research in this area is encouraged to explore the clinical relevance of these findings and their implications for prostate cancer treatment.
Source link
Oncology,Urology